Geode Capital Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-880,546
Closed -$5.14M 4570
2025
Q1
$5.14M Buy
880,546
+52,526
+6% +$277K ﹤0.01% 2639
2024
Q4
$3.08M Sell
828,020
-7,184
-0.9% -$33.2K ﹤0.01% 2973
2024
Q3
$4.67M Buy
835,204
+612
+0.1% +$4.28K ﹤0.01% 2791
2024
Q2
$7.03M Buy
834,592
+34,064
+4% +$363K ﹤0.01% 2547
2024
Q1
$11.6M Buy
800,528
+31,875
+4% +$527K ﹤0.01% 2239
2023
Q4
$16.5M Buy
768,653
+39,079
+5% +$697K ﹤0.01% 2031
2023
Q3
$14M Buy
729,574
+27,869
+4% +$594K ﹤0.01% 2050
2023
Q2
$17.8M Buy
701,705
+42,992
+7% +$1.24M ﹤0.01% 1929
2023
Q1
$23.8M Buy
658,713
+31,475
+5% +$1.11M ﹤0.01% 1675
2022
Q4
$24.8M Buy
627,238
+21,847
+4% +$908K ﹤0.01% 1629
2022
Q3
$28.2M Buy
605,391
+14,417
+2% +$669K ﹤0.01% 1502
2022
Q2
$25.9M Sell
590,974
-9,180
-2% -$505K ﹤0.01% 1570
2022
Q1
$43.4M Buy
600,154
+28,200
+5% +$2.03M 0.01% 1354
2021
Q4
$46.4M Buy
571,954
+10,053
+2% +$1.01M 0.01% 1363
2021
Q3
$65.4M Sell
561,901
-20,695
-4% -$2.71M 0.01% 1048
2021
Q2
$96.6M Buy
582,596
+24,410
+4% +$3.81M 0.01% 805
2021
Q1
$77.9M Buy
558,186
+44,675
+9% +$7.29M 0.01% 905
2020
Q4
$88.9M Buy
513,511
+28,714
+6% +$4.65M 0.01% 758
2020
Q3
$67.5M Sell
484,797
-10,205
-2% -$1.36M 0.01% 768
2020
Q2
$59.1M Buy
495,002
+53,683
+12% +$6.37M 0.01% 807
2020
Q1
$44.1M Buy
441,319
+35,587
+9% +$4.28M 0.01% 829
2019
Q4
$47.7M Buy
405,732
+26,664
+7% +$2.64M 0.01% 968
2019
Q3
$32.6M Buy
379,068
+10,308
+3% +$780K 0.01% 1141
2019
Q2
$23.9M Buy
368,760
+28,306
+8% +$1.76M 0.01% 1360
2019
Q1
$21.3M Buy
340,454
+31,459
+10% +$1.48M 0.01% 1372
2018
Q4
$12M Buy
308,995
+26,356
+9% +$1.17M ﹤0.01% 1665
2018
Q3
$16.1M Buy
282,639
+18,202
+7% +$1.14M ﹤0.01% 1569
2018
Q2
$21.1M Buy
264,437
+23,015
+10% +$1.91M 0.01% 1307
2018
Q1
$20.9M Buy
241,422
+5,539
+2% +$447K 0.01% 1230
2017
Q4
$16.3M Buy
235,883
+1,428
+0.6% +$114K 0.01% 1426
2017
Q3
$21.3M Buy
234,455
+47,633
+25% +$4.08M 0.01% 1190
2017
Q2
$13.9M Buy
186,822
+11,056
+6% +$886K 0.01% 1456
2017
Q1
$16.5M Buy
175,766
+11,404
+7% +$1.03M 0.01% 1296
2016
Q4
$11.9M Buy
164,362
+12,651
+8% +$1.08M 0.01% 1459
2016
Q3
$15.8M Buy
151,711
+48,149
+46% +$4.35M 0.01% 1169
2016
Q2
$7.64M Buy
103,562
+13,895
+15% +$943K ﹤0.01% 1635
2016
Q1
$5.04K Buy
89,667
+1,907
+2% +$112K ﹤0.01% 1861
2015
Q4
$5.92M Buy
87,760
+4,661
+6% +$250K ﹤0.01% 1750
2015
Q3
$3.85M Buy
83,099
+1,871
+2% +$90.7K ﹤0.01% 2008
2015
Q2
$4.37M Buy
81,228
+35,865
+79% +$1.83M ﹤0.01% 1977
2015
Q1
$2.17M Buy
45,363
+27,811
+158% +$1.21M ﹤0.01% 2383
2014
Q4
$678K Buy
+17,552
New +$553K ﹤0.01% 3043

Other funds holding NVRO

Geode Capital Management's NVRO Position: Q2 2025 in Review

Geode Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 880,546 shares — an estimated $5.14M sold.

Geode Capital Management first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $96.6M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Geode Capital Management reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 880,546 NEVRO CORP. shares in Q2 2025, an estimated $5.14M.
  • Geode Capital Management first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
  • Geode Capital Management's NEVRO CORP. position peaked at $96.6M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.